middle.news
How LTR Pharma’s Nasal Sprays Are Poised to Transform Men’s Health Markets
8:50am on Tuesday 29th of July, 2025 AEST
•
Pharmaceuticals
Read Story
How LTR Pharma’s Nasal Sprays Are Poised to Transform Men’s Health Markets
8:50am on Tuesday 29th of July, 2025 AEST
Key Points
SPONTAN now available across 3,900 Symbion pharmacies under Special Access Scheme
ROXUS development milestones achieved, targeting US market launch H1 2026
New OROFLOW collaboration targets $4.5 billion oesophageal motility disorder market
Phase II pharmacokinetic clinical trial preparations underway following FDA guidance
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ltr Pharma (ASX:LTP)
OPEN ARTICLE